United States· US:70710-1467_f8cd3220-beeb-49b7-845a-d1bbb0476377
Colestipol hydrochloride
A colestipol product containing colestipol hydrochloride, registered in United States by Zydus Pharmaceuticals USA Inc.. The same ATC class is registered in 7 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Colestipol is registered in 7 of 19 countries.
Countries holding a registration under ATC C10AC02 (colestipol), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 5 of them publish a price we can compare per daily dose
Colestipol · ATC C10AC02
7 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- Norwayprice
- Spainprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- COLESTIPOL HYDROCHLORIDE
- Manufacturer
- Zydus Pharmaceuticals USA Inc.
- Country
- United States (US)
- ATC code
- C10AC02
- ATC class
- Colestipol
- Defined daily dose
- 20 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc117071014675500 TABLET, FILM COATED in 1 BOTTLE (70710-1467-5)
- ndc117071014677120 TABLET, FILM COATED in 1 BOTTLE (70710-1467-7)
- ndc1170710-1467-5
- ndc1170710-1467-7
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
70 interactions on record for colestipol.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Colestipol · interactions on record
70 records
- 3 severe
- 54 moderate
- 8 minor
Most severe, free to view
- Mycophenolic acidL04AA06severe
- TeriflunomidL04AA31severe
- TeriflunomideL04AK02severe
- Chenodeoxycholic acidA05AA01moderate
5 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Colestipol in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dbfe8da8-ca65-4e55-bbe8-42d8f647de78 GET /v1/drugs/dbfe8da8-ca65-4e55-bbe8-42d8f647de78?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "1",
"substance": "COLESTIPOL HYDROCHLORIDE",
"productndc": "70710-1467",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "g/1",
"application_number": "ANDA215223",
"marketing_category": "ANDA"
}See everything about colestipol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.